Janes Capital Partners co-advises TDK Hutchinson Technology on the divestiture of its medical business to Resonetics, a portfolio company of GTCR
Janes Capital Partners co-advises TDK Hutchinson Technology on the divestiture of its medical business to Resonetics, a portfolio company of GTCR
09/01/2020